X4 Pharmaceuticals (XFOR) Treasury Shares (2017 - 2021)

X4 Pharmaceuticals (XFOR) has reported Treasury Shares for 3 consecutive years, with $229885.0 the latest figure, recorded in Q2 2021.

• For the quarter ending Q2 2021, Treasury Shares changed N/A year-over-year to $229885.0; the trailing twelve-month figure through Jun 2021 stood at $229885.0 (changed N/A YoY), and the FY2018 full-year result was $40.1 million, up 5.42% from the prior year.
• Treasury Shares steadied at $229885.0 in Q2 2021 per XFOR's latest filing, from $229885.0 in the prior quarter.
• Across five years, Treasury Shares topped out at $40.1 million in Q3 2018 and bottomed at $229885.0 in Q1 2021.
• Historically, Treasury Shares has averaged $27.6 million across 3 years, with a median of $37.4 million in 2018.
• The widest YoY moves for Treasury Shares: up 5.42% in 2018, down 5.42% in 2018.
• Over 3 years, Treasury Shares stood at $38.0 million in 2017, then climbed by 5.42% to $40.1 million in 2018, then plunged by 99.43% to $229885.0 in 2021.
• According to Business Quant data, Treasury Shares over the past three periods registered $229885.0, $229885.0, and $40.1 million for Q2 2021, Q1 2021, and Q4 2018 respectively.